Search Results - Hopf-Estandía, Karen

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study

    Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study by Amezcua-Guerra, Luis M., Espinosa-Bautista, Fernanda, Hopf-Estandía, Karen, Valdivieso-Ruiz, Melisa, Coronel, Dania, Robledo, Sandra, Ramos-Rosillo, Varna, del Rocío Martínez-Alvarado, María, Patlán, Mariana, Páez, Araceli, Silveira, Luis H., Tavera-Alonso, Claudia, Massó, Felipe, Soto-Fajardo, Carina, Pineda, Carlos

    Published in Clinical rheumatology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Senescent CD4 + CD28 null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study

    Senescent CD4 + CD28 null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot stud... by Amezcua-Guerra, Luis M, Espinosa-Bautista, Fernanda, Hopf-Estandía, Karen, Valdivieso-Ruiz, Melisa, Coronel, Dania, Robledo, Sandra, Ramos-Rosillo, Varna, Del Rocío Martínez-Alvarado, María, Patlán, Mariana, Páez, Araceli, Silveira, Luis H, Tavera-Alonso, Claudia, Massó, Felipe, Soto-Fajardo, Carina, Pineda, Carlos

    Published in Clinical rheumatology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: